RZLT vs SBFM

Rezolute, Inc. vs Sunshine Biopharma Inc. — Valuation Comparison 2026

RZLT

Pharmaceutical Preparations
Rezolute, Inc.
Quality
4.0
out of 10
Value Trap
30
LOW
Price
$3.30
Last close
Models
7/13
Active
VS

SBFM

Pharmaceutical Preparations
Sunshine Biopharma Inc.
Quality
5.8
out of 10
Value Trap
24
SAFE
Price
$0.25
Last close
Models
2/13
Active

Model-by-Model Comparison

ModelType RZLT Fair ValueRZLT Upside SBFM Fair ValueSBFM Upside
Bayesian DCF Intrinsic $0.91 -72.4% $0.89 +249.2%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $1.46 -55.6%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $5.98 +466.8%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for RZLT vs SBFM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

RZLT vs SBFM — Which Stock Is More Undervalued?

SBFM scores higher with a 5.8/10 quality rating vs RZLT's 4.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Rezolute, Inc. (RZLT) and Sunshine Biopharma Inc. (SBFM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

RZLT currently trades at $3.30 with a QOC of 4.0/10, while SBFM trades at $0.25 with a QOC of 5.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).